| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 152,407 | Sold Some | -25,096 | -14.13 % | $1,144,577 | $1,101,903 | $-42,674 | -3.72 % | $7,027 | | | | | | News Article | History of Amvescap Plc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | | Sold All | -493,440 | -100 % | | | | -3.72 % | $138,163 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Simcere Pharmaceutical Group |
| 2009-11-16 | 2009-09-30 | 13F-HR | Kleinheinz Capital Partners Inc | Institution | 326,500 | Added More | 185,000 | 130.74 % | $2,494,460 | $2,360,595 | $-133,865 | -5.36 % | $-75,850 | | | | | | News Article | History of Kleinheinz Capital Partners Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 79,842 | New Holding | 79,842 | 100 % | $609,993 | $577,258 | $-32,735 | -5.36 % | $-32,735 | | | | | | News Article | History of Morgan Stanley Ownership Of Simcere Pharmaceutical Group |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | | Sold All | -40,147 | -100 % | | | | -5.36 % | $16,460 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wellington Management Co Llp | Institution | 3,790,832 | Added More | 26,127 | 0.69 % | $28,961,956 | $27,407,715 | $-1,554,241 | -5.36 % | $-10,712 | | | | | | News Article | History of Wellington Management Co Llp Ownership Of Simcere Pharmaceutical Group |
| 2009-11-16 | 2009-09-30 | 13F-HR | Wexford Capital Llc | Institution | 10,300 | Sold Some | -4,300 | -29.45 % | $78,692 | $74,469 | $-4,223 | -5.36 % | $1,763 | | | | | | News Article | History of Wexford Capital Llc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | | Sold All | -57,673 | -100 % | | | | -2.82 % | $12,111 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 1,420,512 | Sold Some | -3,200 | -0.22 % | $10,568,609 | $10,270,302 | $-298,308 | -2.82 % | $672 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martin Currie Inc | Institution | 107,800 | No Change | 0 | 0 % | $802,032 | $779,394 | $-22,638 | -2.82 % | $0 | | | | | | News Article | History of Martin Currie Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price T Rowe Associates Inc | Institution | 442,600 | Sold Some | -1,900 | -0.42 % | $3,292,944 | $3,199,998 | $-92,946 | -2.82 % | $399 | | | | | | News Article | History of Price T Rowe Associates Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-10-30 | 13F-HR | Td Asset Management Inc | Institution | 23,100 | No Change | 0 | 0 % | $175,560 | $167,013 | $-8,547 | -4.86 % | $0 | | | | | | News Article | History of Td Asset Management Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Aviva Plc | Institution | 17,700 | New Holding | 17,700 | 100 % | $134,520 | $127,971 | $-6,549 | -4.86 % | $-6,549 | | | | | | News Article | History of Aviva Plc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 7,591 | No Change | 0 | 0 % | $57,692 | $54,883 | $-2,809 | -4.86 % | $0 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Claymore Advisors Llc | Institution | 38,699 | Added More | 9,662 | 33.27 % | $294,112 | $279,794 | $-14,319 | -4.86 % | $-3,575 | | | | | | News Article | History of Claymore Advisors Llc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Genesis Asset Managers Llp | Institution | 2,244,542 | No Change | 0 | 0 % | $17,058,519 | $16,228,039 | $-830,481 | -4.86 % | $0 | | | | | | News Article | History of Genesis Asset Managers Llp Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kinetics Asset Management Inc | Institution | | Sold All | -51,000 | -100 % | | | | -4.86 % | $18,870 | | | | | | News Article | History of Kinetics Asset Management Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 181,997 | Added More | 168,416 | 1240.08 % | $1,383,177 | $1,315,838 | $-67,339 | -4.86 % | $-62,314 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 27,300 | New Holding | 27,300 | 100 % | $207,480 | $197,379 | $-10,101 | -4.86 % | $-10,101 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -922 | -100 % | | | | -4.86 % | $341 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Simcere Pharmaceutical Group |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | 16,514 | Sold Some | -78,693 | -82.65 % | $131,617 | $119,396 | $-12,220 | -9.28 % | $58,233 | | | | | | News Article | History of Citigroup Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 93,821 | Added More | 24,927 | 36.18 % | $747,753 | $678,326 | $-69,428 | -9.28 % | $-18,446 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Simcere Pharmaceutical Group |
| 2009-11-10 | 2009-09-30 | 13F-HR | Royce And Associates Llc | Institution | 345,700 | Added More | 48,800 | 16.43 % | $2,755,229 | $2,499,411 | $-255,818 | -9.28 % | $-36,112 | | | | | | News Article | History of Royce And Associates Llc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 73,159 | Added More | 23,528 | 47.40 % | $583,077 | $528,940 | $-54,138 | -9.28 % | $-17,411 | | | | | | News Article | History of Ubs Ag Ownership Of Simcere Pharmaceutical Group |
| 2009-11-06 | 2009-09-30 | 13F-HR | Waddell And Reed Financial Inc | Institution | 253,920 | Sold Some | -319,586 | -55.72 % | $1,952,645 | $1,835,842 | $-116,803 | -5.98 % | $147,010 | | | | | | News Article | History of Waddell And Reed Financial Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-11-04 | 2009-09-30 | 13F-HR | Geewax Plus Partners Llc | Institution | | Sold All | -2,200 | -100 % | | | | -6.10 % | $1,034 | | | | | | News Article | History of Geewax Plus Partners Llc Ownership Of Simcere Pharmaceutical Group |
| 2009-10-30 | 2009-09-30 | 13F-HR | Tocqueville Asset Management Lp | Institution | 111,800 | New Holding | 111,800 | 100 % | $883,220 | $808,314 | $-74,906 | -8.48 % | $-74,906 | | | | | | News Article | History of Tocqueville Asset Management Lp Ownership Of Simcere Pharmaceutical Group |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 57,673 | Sold Some | -2,400 | -3.99 % | $441,775 | $416,976 | $-24,799 | -5.61 % | $1,032 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Simcere Pharmaceutical Group |
| 2009-09-29 | 2009-07-31 | N-Q | Seligman Global Fund Series Inc - Emerging Markets Fund | Emerging Markets | 55,573 | New Holding | 55,573 | 100 % | $437,360 | $401,793 | $-35,567 | -8.13 % | $-35,567 | | | | | | News Article | History of Seligman Global Fund Series Inc - Emerging Markets Fund Ownership Of Simcere Pharmaceutical Group |
| 2009-09-28 | 2009-07-31 | N-Q | Idex Mutual Fds - Transamerica Wmc Emerging Markets | No Data | 93,700 | Added More | 15,500 | 19.82 % | $735,545 | $677,451 | $-58,094 | -7.89 % | $-9,610 | | | | | | News Article | History of Idex Mutual Fds - Transamerica Wmc Emerging Markets Ownership Of Simcere Pharmaceutical Group |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 7,591 | Sold Some | -1,056 | -12.21 % | $62,322 | $54,883 | $-7,439 | -11.93 % | $1,035 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Simcere Pharmaceutical Group |
| 2009-09-04 | 2009-08-17 | N-CSR | John Hancock Trust - Health Sciences Trust | Health/Biotech | | Sold All | -22,600 | -100 % | | | | -7.66 % | $13,560 | | | | | | News Article | History of John Hancock Trust - Health Sciences Trust Ownership Of Simcere Pharmaceutical Group |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 177,503 | Sold Some | -184,305 | -50.94 % | $1,309,972 | $1,283,347 | $-26,625 | -2.03 % | $27,646 | | | | | | News Article | History of Amvescap Plc Ownership Of Simcere Pharmaceutical Group |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 493,440 | New Holding | 493,440 | 100 % | $3,769,882 | $3,567,571 | $-202,310 | -5.36 % | $-202,310 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Simcere Pharmaceutical Group |
| 2009-08-27 | 2009-06-30 | N-Q | Ivy Funds - Ivy Pacific Opportunities Fund | Pacific Ex Japan | 574 | No Change | 0 | 0 % | $4,454 | $4,150 | $-304 | -6.82 % | $0 | | | | | | News Article | History of Ivy Funds - Ivy Pacific Opportunities Fund Ownership Of Simcere Pharmaceutical Group |
| 2009-08-27 | 2009-06-30 | N-Q | Wells Fargo Funds Trust - Asia Pacific Fund | Pacific Region | 215,665 | New Holding | 215,665 | 100 % | $1,673,560 | $1,559,258 | $-114,302 | -6.82 % | $-114,302 | | | | | | News Article | History of Wells Fargo Funds Trust - Asia Pacific Fund Ownership Of Simcere Pharmaceutical Group |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss! There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |